| 000 | 01855 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516133234.0 | ||
| 264 | 0 | _c20130828 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1873-2623 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2012.10.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChakkera, H A | |
| 245 | 0 | 0 |
_aGenetic differences in Native Americans and tacrolimus dosing after kidney transplantation. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _c |
||
| 300 |
_a137-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aIndians, North American |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xdrug therapy |
| 650 | 0 | 4 |
_aKidney Transplantation _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 |
_aTacrolimus _xpharmacokinetics |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aChang, Y-H | |
| 700 | 1 | _aBodner, J K | |
| 700 | 1 | _aBehmen, S | |
| 700 | 1 | _aHeilman, R L | |
| 700 | 1 | _aReddy, K S | |
| 700 | 1 | _aMulligan, D C | |
| 700 | 1 | _aMoss, A A | |
| 700 | 1 | _aKhamash, H | |
| 700 | 1 | _aKatariya, N | |
| 700 | 1 | _aHewitt, W R | |
| 700 | 1 | _aPitta, T L | |
| 700 | 1 | _aFrassetto, L A | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 45 _gno. 1 _gp. 137-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2012.10.023 _zAvailable from publisher's website |
| 999 |
_c22471623 _d22471623 |
||